Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.

Etzerodt A, Tsalkitzi K, Maniecki M, Damsky W, Delfini M, Baudoin E, Moulin M, Bosenberg M, Graversen JH, Auphan-Anezin N, Moestrup SK, Lawrence T.

J Exp Med. 2019 Aug 2. pii: jem.20182124. doi: 10.1084/jem.20182124. [Epub ahead of print]

PMID:
31375534
2.

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.

Eur J Haematol. 2014 Jul;93(1):41-7. doi: 10.1111/ejh.12296. Epub 2014 Mar 20.

PMID:
24612259
3.

A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness.

Rødgaard-Hansen S, Rafique A, Christensen PA, Maniecki MB, Sandahl TD, Nexø E, Møller HJ.

Clin Chem Lab Med. 2014 Mar;52(3):453-61. doi: 10.1515/cclm-2013-0451.

PMID:
24114918
4.

Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease.

Wilhelmsen P, Kjær J, Thomsen KL, Nielsen CT, Dige A, Maniecki MB, Heegaard N, Grønbæk H, Dahlerup J, Handberg A.

Arch Physiol Biochem. 2013 Dec;119(5):202-8. doi: 10.3109/13813455.2013.808671. Epub 2013 Jul 17.

PMID:
23862574
5.

Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption.

Etzerodt A, Kjolby M, Nielsen MJ, Maniecki M, Svendsen P, Moestrup SK.

Antioxid Redox Signal. 2013 Jun 10;18(17):2254-63. doi: 10.1089/ars.2012.4605. Epub 2012 Aug 29.

PMID:
22793784
6.

Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.

Maniecki MB, Etzerodt A, Ulhøi BP, Steiniche T, Borre M, Dyrskjøt L, Orntoft TF, Moestrup SK, Møller HJ.

Int J Cancer. 2012 Nov 15;131(10):2320-31. doi: 10.1002/ijc.27506. Epub 2012 Mar 28.

7.

Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163.

Etzerodt A, Maniecki MB, Graversen JH, Møller HJ, Torchilin VP, Moestrup SK.

J Control Release. 2012 May 30;160(1):72-80. doi: 10.1016/j.jconrel.2012.01.034. Epub 2012 Jan 27.

PMID:
22306335
8.

Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.

Maniecki MB, Etzerodt A, Moestrup SK, Møller HJ, Graversen JH.

Immunobiology. 2011 Aug;216(8):882-90. doi: 10.1016/j.imbio.2011.02.001. Epub 2011 Feb 22.

PMID:
21458881
9.

Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes?

Maniecki MB, Hasle H, Bendix K, Møller HJ.

Leuk Res. 2011 Jun;35(6):e84-6. doi: 10.1016/j.leukres.2011.01.025. Epub 2011 Feb 16. No abstract available.

PMID:
21329979
10.

Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.

Etzerodt A, Maniecki MB, Møller K, Møller HJ, Moestrup SK.

J Leukoc Biol. 2010 Dec;88(6):1201-5. doi: 10.1189/jlb.0410235. Epub 2010 Aug 31.

PMID:
20807704
11.

Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.

Møller HJ, Nielsen MJ, Maniecki MB, Madsen M, Moestrup SK.

Immunobiology. 2010 May;215(5):406-12. doi: 10.1016/j.imbio.2009.05.003. Epub 2009 Jul 5.

PMID:
19581020
12.

Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.

Jensen TO, Schmidt H, Møller HJ, Høyer M, Maniecki MB, Sjoegren P, Christensen IJ, Steiniche T.

J Clin Oncol. 2009 Jul 10;27(20):3330-7. doi: 10.1200/JCO.2008.19.9919. Epub 2009 Jun 15.

PMID:
19528371
13.

Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin.

Maniecki MB, Hasle H, Friis-Hansen L, Lausen B, Nielsen OJ, Bendix K, Moestrup SK, Møller HJ.

Blood. 2008 Aug 15;112(4):1510-4. doi: 10.1182/blood-2007-09-114165. Epub 2008 Jun 11.

14.

CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes.

Maniecki MB, Møller HJ, Moestrup SK, Møller BK.

Immunobiology. 2006;211(6-8):407-17. Epub 2006 Jul 20.

PMID:
16920480
15.

Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.

Görges R, Maniecki M, Jentzen W, Sheu SN, Mann K, Bockisch A, Janssen OE.

Eur J Endocrinol. 2005 Jul;153(1):49-55.

PMID:
15994745
16.

Identification of the receptor scavenging hemopexin-heme complexes.

Hvidberg V, Maniecki MB, Jacobsen C, Højrup P, Møller HJ, Moestrup SK.

Blood. 2005 Oct 1;106(7):2572-9. Epub 2005 Jun 9.

17.

[Noninvasive fetal RHD genotyping in a previously Rh-isoimmunized pregnant woman].

Maniecki MB, Møller HJ, Skajaa K.

Ugeskr Laeger. 2005 Apr 18;167(16):1761-2. Danish. No abstract available.

PMID:
15898610

Supplemental Content

Loading ...
Support Center